Michael Cole, healthcare industry leader for Alvarez & Marsal's Global Transaction Advisory Group, pointed out that this year saw the highest third-quarter IPO volume in the last 20 years despite the drop from the second quarter of 2021 in S&P Global Market Intelligence.
"There's just a lot of demand for companies that can do a lot of things, and in healthcare that's responding to the need for innovation, namely, in the life sciences and biotech side on the heels of the pandemic and the increased need for digitization," Cole said.
Read the full article here
Alvarez & Marsal’s Global Transaction Advisory Group Appoints Capital Markets Accounting Advisory Leader for Australia
March 31, 2026
New Managing Director Jenny Arrand to lead firm’s CMAA capabilities in the market, enhancing its globally integrated, end-to-end advisory offering
The Evolution of Private Equity: Performance, Persistence and the Path Ahead with Steven Kaplan
March 2, 2026
Anthony Consoli and Steven Kaplan discuss the early foundations of private equity.
2025 in Review, 2026 in Focus: The Next Cycle for Private Equity and M&A
January 29, 2026
Anthony Consoli and Peter Massumi discuss the fast-changing dynamics of today’s middle-market deal environment.
Alvarez & Marsal's Global Transaction Advisory Group's Canadian Practice Bolsters Industry Expertise to Drive Energy & Infrastructure Growth
January 29, 2026
Alvarez & Marsal (“A&M”), a leading global professional services firm, today announced that Geoff Hayes has joined its Global Transaction Advisory Group (Global TAG) as a Managing Director.
